Home Page Settlements $1.3M Awarded in Actos Bladder Cancer Lawsuit
$1.3M Awarded in Actos Bladder Cancer Lawsuit
This is a settlement for the Actos lawsuit.
Los Angeles, CA: The plaintiff in an Actos bladder cancer lawsuit against Takeda Pharmaceutical Co, the makers of the diabetes drug, has been awarded $1,334,636 million in punitive damages by the jury hearing his case.
The jury found that Takeda had acted with reckless indifference for the health of Mr. Kristufek, a retired teacher who alleged that Actos had caused him to develop bladder cancer.
The $1.3 million in punitive damages is additional to a $2.3 million award the jury handed down on the day before, after agreeing that Takeda had failed to provide adequate warnings about the drug' association with bladder cancer and that the medication had been a significant cause of Mr. Kristufek' condition.
Kristufek' is the fifth Actos-related case out of eight in which juries have returned verdicts on behalf of plaintiffs, and only the second in which the company has faced punitive damages. Further, his is the second Actos-related case to win in Philadelphia, with a jury awarding $2 million in damages in a case that cited similar allegations for a woman.
The case is John Kristufek v. Takeda Pharmaceuticals America Inc., case number 120702275, in the Court of Common Pleas of the State of Pennsylvania, County of Philadelphia.
Legal HelpIf you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please fill in our form.
Published on Feb-16-15
READ MORE [ Consumer Fraud Settlements and Legal News ]
READ MORE [ Drugs/Medical Settlements and Legal News ]
READ MORE [ Personal Injury Settlements and Legal News ]
ADD YOUR COMMENT ON THIS ISSUE